iScience,
Год журнала:
2023,
Номер
27(1), С. 108745 - 108745
Опубликована: Дек. 19, 2023
Alzheimer's
disease
(AD)
is
characterized
by
peri-neuronal
amyloid
plaque
and
intra-neuronal
neurofibrillary
tangles.
These
aggregates
are
identified
the
immunodetection
of
"seed"
proteins
(Aβ
Frontiers in Aging Neuroscience,
Год журнала:
2024,
Номер
16
Опубликована: Май 14, 2024
As
the
global
population
ages,
incidence
of
elderly
patients
with
dementia,
represented
by
Alzheimer's
disease
(AD),
will
continue
to
increase.
Previous
studies
have
suggested
that
β-amyloid
protein
(Aβ)
deposition
is
a
key
factor
leading
AD.
However,
clinical
efficacy
treating
AD
anti-Aβ
antibodies
not
satisfactory,
suggesting
Aβ
amyloidosis
may
be
pathological
change
rather
than
Identification
causes
and
development
corresponding
prevention
treatment
strategies
an
important
goal
current
research.
Following
discovery
soluble
oligomeric
forms
(AβO)
in
1998,
scientists
began
focus
on
neurotoxicity
AβOs.
endogenous
neurotoxin,
active
growth
AβOs
can
lead
neuronal
death,
which
believed
occur
before
plaque
formation,
are
factors
PANoptosis,
newly
proposed
concept
cell
death
includes
known
modes
pyroptosis,
apoptosis,
necroptosis,
form
regulated
PANoptosome
complex.
Neuronal
survival
depends
proper
mitochondrial
function.
Under
conditions
AβO
interference,
dysfunction
occurs,
releasing
lethal
contents
as
potential
upstream
effectors
PANoptosome.
Considering
critical
role
neurons
cognitive
function
well
regulatory
survival,
investigation
mechanisms
PANoptosis
crucial.
This
review
describes
disruption
elucidates
how
activate
causing
during
AD,
providing
guidance
for
targeted
strategies.
Ageing Research Reviews,
Год журнала:
2024,
Номер
98, С. 102320 - 102320
Опубликована: Май 6, 2024
Aging
is
a
gradual
and
irreversible
natural
process.
With
aging,
the
body
experiences
functional
decline,
effects
amplify
vulnerability
to
range
of
age-related
diseases,
including
neurodegenerative,
cardiovascular,
metabolic
diseases.
Within
aging
process,
morphology
function
mitochondria
endoplasmic
reticulum
(ER)
undergo
alterations,
particularly
in
structure
connecting
these
organelles
known
as
mitochondria-associated
membranes
(MAMs).
MAMs
serve
vital
intracellular
signaling
hubs,
facilitating
communication
between
ER
when
regulating
various
cellular
events,
calcium
homeostasis,
lipid
metabolism,
mitochondrial
function,
apoptosis.
The
formation
partly
dependent
on
interaction
vesicle-associated
membrane
protein-associated
protein-B
(VAPB)
protein
tyrosine
phosphatase-interacting
protein-51
(PTPIP51).
Accumulating
evidence
has
begun
elucidate
pivotal
role
VAPB-PTPIP51
tether
initiation
progression
In
this
study,
we
delineate
intricate
multifunctional
discuss
its
profound
implications
aging-associated
Moreover,
provide
comprehensive
overview
potential
therapeutic
interventions
pharmacological
agents
targeting
VAPB-PTPIP51-mediated
MAMs,
thereby
offering
glimmer
hope
mitigating
processes
treating
disorders.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(15), С. 12025 - 12025
Опубликована: Июль 27, 2023
Sigma
(σ)
receptors
are
a
class
of
unique
proteins
with
two
subtypes:
the
sigma-1
(σ1)
receptor
which
is
situated
at
mitochondria-associated
endoplasmic
reticulum
(ER)
membrane
(MAM),
and
sigma-2
(σ2)
receptor,
located
in
ER-resident
membrane.
Increasing
evidence
indicates
involvement
both
σ1
σ2
pathogenesis
Alzheimer’s
disease
(AD),
thus
these
represent
potentially
effective
biomarkers
for
emerging
AD
therapies.
The
availability
optimal
radioligands
positron
emission
tomography
(PET)
neuroimaging
humans
will
provide
tools
to
monitor
progression
treatment
outcomes.
In
this
review,
we
first
summarize
significance
pathophysiology
highlight
therapeutic
strategies
related
receptors.
We
then
survey
potential
PET
radioligands,
an
emphasis
on
requirements
imaging
or
humans.
Finally,
discuss
current
challenges
development
receptors,
opportunities
elucidate
as
novel
early
diagnosis,
monitoring
drug
efficacy.
Molecular Medicine,
Год журнала:
2025,
Номер
31(1)
Опубликована: Фев. 18, 2025
Abstract
Abnormal
glucose
metabolism
inevitably
disrupts
normal
neuronal
function,
a
phenomenon
widely
observed
in
Alzheimer’s
disease
(AD).
Investigating
the
mechanisms
of
metabolic
adaptation
during
progression
has
become
central
focus
research.
Considering
that
impaired
is
closely
related
to
decreased
insulin
signaling
and
resistance,
new
concept
"type
3
diabetes
mellitus
(T3DM)"
been
coined.
T3DM
specifically
refers
brain’s
neurons
becoming
unresponsive
insulin,
underscoring
strong
link
between
AD.
Recent
studies
reveal
brain
exhibit
mitochondrial
dysfunction,
reduced
metabolism,
elevated
lactate
levels.
These
findings
suggest
caused
by
may
lead
compensatory
shift
toward
glycolysis.
Consequently,
this
review
aims
explore
underlying
causes
elucidate
how
resistance
drives
reprogramming
AD
progression.
Additionally,
it
highlights
therapeutic
strategies
targeting
sensitivity
function
as
promising
avenues
for
successful
development
treatments.
ACS Chemical Biology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 15, 2025
Flavonoids
such
as
sterubin
and
fisetin─and
derivatives
thereof─show
strong
neuroprotective
effects
in
vitro
well
vivo,
combined
with
negligible
toxicity
can
therefore
be
considered
novel
treatment
options
for
neurodegenerative
diseases
Alzheimer's
disease.
However,
their
subcellular
locations
responsible
neuroprotection
exact
modes
of
action
still
remain
unclear.
Here,
we
present
chemical
probes
based
on
both
flavonoids
fisetin
that
were
utilized
fluorescence
microscopy
click-correlative
light
electron
to
detect
visualize
the
localization
specific
intracellular
targets.
We
successfully
adapted
workflow
correlative
a
click-chemistry-based
approach
murine
hippocampal
cell
line
(HT22)
ultrathin
resin
sections
making
visualization
small
molecule
first
time
possible
this
setup.
Utilizing
newly
technique,
could
demonstrate
show
enrichment
endoplasmic
reticulum.
Chemical Biology Letters,
Год журнала:
2023,
Номер
10(4)
Опубликована: Дек. 1, 2023
Neurodegenerative
diseases,
marked
by
the
gradual
deterioration
of
neuronal
structure
and
function,
impose
a
significant
burden
on
global
healthcare
systems.
Oxidative
stress,
resulting
from
an
imbalance
between
reactive
oxidant
production
cellular
antioxidant
defense,
is
believed
to
play
role
in
development
various
neurodegenerative
disorders,
including
Alzheimer's
disease,
Parkinson's
Huntington's
disease.
Recently,
there
has
been
growing
interest
exploring
small
compounds
as
potential
therapeutic
agents
counteract
oxidative
stress.
In
addition
highlighting
molecules
prevent
stress-mediated
damage,
this
article
provides
overview
function
stress
illnesses.
Targeting
numerous
stress-related
pathways,
number
molecules,
both
natural
synthetic
antioxidants,
have
shown
promise
for
neuroprotective
benefits.
These
substances
neutralise
oxidants,
boost
endogenous
defences,
reduce
inflammation,
alter
mitochondrial
encourage
neurotrophic
growth.
URN:NBN:sciencein.cbl.2023.v10.626